Current approved therapeutic strategies for IPF and LC treatment.

Traditional Chinese medicine combined with pulmonary drug delivery

A comprehensive comparison of the safety and efficacy of drugs in

Massimo DOMINICI, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Department of Medical and Surgical Sciences for Children and Adults

Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF

Valentina MASCIALE, PostDoc Position, Doctor of Philosophy, Polyclinic of Modena, Modena, PM, Department of Pediatric Surgery

Pie chart of ILD severity score of chILD in Egyptian patients

Idiopathic Pulmonary Fibrosis

PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting

PDF) Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development

Giorgia GUAITOLI, Resident, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Medical Oncology

Novel molecular targets in IPF and main related pathways

Emerging delivery approaches for targeted pulmonary fibrosis